Response Genetics to Raise $4M in Private Placement | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Genetics said that it expects to close today a private placement of its common shares, through which the firm expects to raise $4 million.

The Los Angeles-based molecular diagnostics firm said that it has signed a purchase agreement with certain new and existing investors and funds managed by Landsdowne Partners. It expects to sell to those buyers 3,005,349 of newly issued common shares at a price of $1.31 per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.